Clincosm LogoSign in Get a demo

anal squamous cell carcinoma

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anal Squamous Cell Carcinoma Trial (Radiotherapy - Low risk group, Radiotherapy - Standard risk group, Radiotherapy -

Not yet recruiting
  • Anal Squamous Cell Carcinoma
  • Radiotherapy - Low risk group
  • +3 more
  • (no location specified)
Sep 18, 2023

Anal Squamous Cell Carcinoma Trial in New York (Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and

Recruiting
  • Anal Squamous Cell Carcinoma
  • Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and Delivery
  • +3 more
  • New York, New York
    Columbia University Irving Medical Center
Apr 27, 2023

AIDS-Related Anal Carcinoma, Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma Trial in United States (drug, radiation,

Recruiting
  • AIDS-Related Anal Carcinoma
  • +22 more
  • San Francisco, California
  • +8 more
Jan 27, 2023

Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Squamous Cell Carcinoma Trial in Philadelphia (Capecitabine,

Active, not recruiting
  • Anal Basaloid Carcinoma
  • +6 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jan 3, 2023

A Global Record of Anal Squamous Cell Carcinoma With and Without

Not yet recruiting
  • Anal Squamous Cell Carcinoma
  • HIV Infections
    • (no location specified)
    Nov 28, 2022

    Anal Squamous Cell Carcinoma, Colorectal Tumors, Soft Tissue Sarcoma Trial (Regorafenib in combination with Tislelizumab)

    Not yet recruiting
    • Anal Squamous Cell Carcinoma
    • +7 more
    • Regorafenib in combination with Tislelizumab
    • (no location specified)
    Oct 12, 2022

    Anal Cancer, Anal Carcinoma, Anal Squamous Cell Carcinoma Trial in Herlev (online adaptive radiotherapy)

    Recruiting
    • Anal Cancer
    • +2 more
    • online adaptive radiotherapy
    • Herlev, Denmark
      Oncology dept, Herlev and Gentofte Hospital
    Aug 2, 2022

    Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

    Terminated
    • Melanoma
    • +8 more
    • GEN-011
    • +3 more
    • Gilbert, Arizona
    • +7 more
    Jul 13, 2022

    Anal Canal Cancer Stage III, Anal Squamous Cell Carcinoma, Anal Canal Cancer Trial in Guangzhou (PD-1 inhibitor, concurrent

    Recruiting
    • Anal Canal Cancer Stage III
    • +3 more
    • PD-1 inhibitor
    • concurrent chemoradiotherapy
    • Guangzhou, Guangdong, China
      The Sixth Affiliated Hospital of Sun Yat-sen University
    May 10, 2022

    Head and Neck Squamous Cell Carcinoma, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma Trial in United States (NKTR-255,

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +4 more
    • Scottsdale, Arizona
    • +11 more
    Mar 31, 2022

    Score With PET/CT for Anal Squamous Cell Cancer

    Recruiting
    • Anal Squamous Cell Carcinoma
    • +9 more
    • Computed Tomography
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 7, 2022

    Anal Canal Cancer, Anal Squamous Cell Carcinoma, Anal Cancer Trial in Guangzhou (Toripalimab)

    Recruiting
    • Anal Canal Cancer
    • +5 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 19, 2021

    Anal Squamous Cell Carcinoma Trial in Spain (panitumumab, mytomicin C, 5-FU, radiation)

    Completed
    • Anal Squamous Cell Carcinoma
    • panitumumab, mytomicin C, 5-FU, radiation
    • Badalona, Barcelona, Spain
    • +19 more
    May 11, 2018

    Proprietary Rectal and Anal Cancer Protein Expression Assays

    Terminated
    • Rectal Adenocarcinoma
    • +2 more
      • Chicago, Illinois
        Rush University Medical Center
      Jan 23, 2018

      Head and Neck Squamous Cell Carcinoma, Anal Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma Trial in United States

      Completed
      • Head and Neck Squamous Cell Carcinoma
      • +6 more
      • Sacramento, California
      • +12 more
      Jun 22, 2017

      Advanced Cancer, Squamous Cell Carcinoma, Carcinoma, Squamous Cell of Head and Neck Trial in United States (Prexasertib)

      Completed
      • Advanced Cancer
      • +5 more
      • Sarasota, Florida
      • +4 more
      May 9, 2016